Switching from Conventional Fibrates to Pemafibrate Has Beneficial Effects on the Renal Function of Diabetic Subjects with Chronic Kidney Disease
CONCLUSION: A switch to pemafibrate may be associated with an elevation in eGFR, but to a lesser extent in patients with poor renal function.PMID:38419467 | DOI:10.4093/dmj.2023.0370
Source: Diabetes and Metabolism Journal - Category: Endocrinology Authors: Rimi Izumihara Hiroshi Nomoto Kenichi Kito Yuki Yamauchi Kazuno Omori Yui Shibayama Shingo Yanagiya Aika Miya Hiraku Kameda Kyu Yong Cho So Nagai Ichiro Sakuma Akinobu Nakamura Tatsuya Atsumi PARM-T2D Study Group Source Type: research
More News: Chronic Kidney Disease | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Fenofibrate | Study | Toxicology | Tricor | Urology & Nephrology